UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4378-4384

2009

Volltextzugriff (PDF)

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

Haematologica (Roma), 2012-05, Vol.97 (5), p.784-796

2012

Volltextzugriff (PDF)

Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities

Folia medica (Plovdiv), 2020-06, Vol.62 (2), p.265-270

2020

Volltextzugriff (PDF)

Industrial digitalisation brings hybrid power to deep-sea ships

Naval architect, 2020-01, p.10

Goranov, Stefan

2020

Volltextzugriff (PDF)

Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations

Haematologica (Roma), 2007-07, Vol.92 (7), p.1000-1001

2007

Volltextzugriff (PDF)

Multiple Myeloma with Advanced Bone Disease and Low Tumor Burden - Different Clinical Presentation but Similar Outcome after Bortezomib-Based Therapy and Radiotherapy

Acta clinica Croatica (Tisak), 2017-06, Vol.56 (2), p.262-268

2017

Volltextzugriff (PDF)

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients – final analysis of a randomized, multicenter, phase III trial

Haematologica (Roma), 2012-10, Vol.97 (10), p.1562-1569

2012

Volltextzugriff (PDF)

WinGD 12X92DF, the Most Powerful Otto-cycle Engine

MTZ worldwide, 2022-05, Vol.83 (5), p.40-47

2022

Volltextzugriff (PDF)

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

British journal of haematology, 2012-10, Vol.159 (1), p.67-77

2012

Volltextzugriff (PDF)

Poems syndrome--a rare variant of plasma cell dyscrasia. Case report and review of literature

Folia medica (Plovdiv), 2009-04, Vol.51 (2), p.5

2009

Volltextzugriff (PDF)

Therapeutic Results in Patients with Hodgkin's Lymphoma Treated with Brentuximab Vedotin — Bulgarian Experience

Blood, 2017-12, Vol.130, p.5193-5193

2017

Volltextzugriff (PDF)

Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma

Folia medica (Plovdiv), 2009-10, Vol.51 (4), p.53

2009

Volltextzugriff (PDF)

Bone lesions in multiple myeloma--the OPG/RANK-ligand system

Folia medica (Plovdiv), 2004, Vol.46 (3), p.5

2004

Volltextzugriff (PDF)

A case of encephalomyelopolyneuropathy in vitamin B12 deficiency

Folia medica (Plovdiv), 2004, Vol.46 (4), p.52

2004

Volltextzugriff (PDF)

Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies

Folia medica (Plovdiv), 2003, Vol.45 (1), p.13

2003

Volltextzugriff (PDF)

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma

Blood, 2009-11, Vol.114 (22), p.959-959

2009

Volltextzugriff (PDF)

Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups

Blood, 2009-11, Vol.114 (22), p.2367-2367

2009

Volltextzugriff (PDF)

Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study

Blood, 2008-11, Vol.112 (11), p.2091-2091

2008

Volltextzugriff (PDF)

Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature

Acta clinica Croatica (Tisak), 2011-06, Vol.50 (2), p.273-279

2011

Volltextzugriff (PDF)

Serum levels of OPG, RANKL and RANKL/OPG ratio in newly-diagnosed patients with multiple myeloma. Clinical correlations

Haematologica (Roma), 2007-07, Vol.92 (7), p.1000-1001

2007

Volltextzugriff (PDF)

Hepatic Hematopoiesis In β- Thalassemia

The Internet journal of hematology, 2009, Vol.5 (2)

2009

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities

Industrial digitalisation brings hybrid power to deep-sea ships

Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations

Multiple Myeloma with Advanced Bone Disease and Low Tumor Burden - Different Clinical Presentation but Similar Outcome after Bortezomib-Based Therapy and Radiotherapy

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients – final analysis of a randomized, multicenter, phase III trial

High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 “ISTAHIT” study

WinGD 12X92DF, the Most Powerful Otto-cycle Engine

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

Poems syndrome--a rare variant of plasma cell dyscrasia. Case report and review of literature

Therapeutic Results in Patients with Hodgkin's Lymphoma Treated with Brentuximab Vedotin — Bulgarian Experience

Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma

Bone lesions in multiple myeloma--the OPG/RANK-ligand system

A case of encephalomyelopolyneuropathy in vitamin B12 deficiency

Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies

High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival – Final Results of the CELSG Phase III CML11 “ISTAHIT” Trial

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma

Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups

Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study

CELSG CML 11 “ISTAHIT” Phase III Study – Planned Interim Analysis: High Doses of Imatinib Mesylate (800mg/day) Significantly Improve Rates of Major and Complete Cytogenetic Remissions (MCR, CCR) in Pretreated Ph+/BCR-ABL+ CML Patients in Chronic Phase

Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature

Serum levels of OPG, RANKL and RANKL/OPG ratio in newly-diagnosed patients with multiple myeloma. Clinical correlations

Hepatic Hematopoiesis In β- Thalassemia

Suchergebnisse filtern